Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant stateGloria V. Echeverria, Helen Piwnica‐Worms, Zhongqi Ge et al.|Science Translational Medicine|2019Cited by 316
Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR<sup>−</sup>/HER2<sup>+</sup>breast cancersRuth Rodríguez‐Barrueco, José M. Silva, David Llobet‐Navàs et al.|Genes & Development|2015Cited by 121